Clinical trials

  • OSIMERTINIB for Non-small cell lung cancer (EGFR-mutant)
  • PN6047 HYDROCHLORIDE for Mechanical allodynia | Peripheral neuropathic pain
  • IFINATAMAB DERUXTECAN for Metastatic castration-resistant prostate cancer
  • KYV-101 for ANCA-associated vasculitis|Granulomatosis with polyangiitis (GPA)|Microscopic polyangiitis (MPA)
  • PLX-PAD cells for Osteoarthritis | Knee osteoarthritis
  • OXALIPLATIN for Gastric adenocarcinoma (diffuse type) | Gastroesophageal junction adenocarcinoma (Type II/III)
  • Ropivacaine hydrochloride for Postmastectomy pain syndrome|Chronic neuropathic pain
  • JNJ-77242113 for Psoriatic arthritis
  • BOSUTINIB for Chronic myeloid leukemia
  • Atezolizumab for Rectal cancer|Colorectal cancer
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for Cholangiocarcinoma | Pancreatic adenocarcinoma
  • FULVESTRANT for ER-positive HER2-negative breast cancer